Recludix Pharma
Howie Bregman has over 13 years of experience in the pharmaceutical industry. Howie began their career in 2007 as a Senior Scientist at Amgen. In 2017, they joined Agios Pharmaceuticals as an Associate Director. In 2020, they moved to Recludix Pharma, where they currently serve as the Sr. Director of Medicinal Chemistry and the Director of Medicinal Chemistry.
Howie Bregman obtained their PhD in Organic Chemistry from the University of Pennsylvania between 2002 and 2007.
This person is not in any offices
Recludix Pharma
Recludix is a leader in developing platform approaches to discover potent and selective inhibitors of challenging protein targets by integrating custom generated DNA-encoded libraries, massively parallel determination of structure activity relationships, and a proprietary screening tool to ensure selectivity.